These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15926870)

  • 21. News in gut-brain communication: a role of peptide YY (PYY) in human obesity and following bariatric surgery?
    Hanusch-Enserer U; Roden M
    Eur J Clin Invest; 2005 Jul; 35(7):425-30. PubMed ID: 16008543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The satiety hormone peptide YY as a regulator of appetite.
    Vincent RP; le Roux CW
    J Clin Pathol; 2008 May; 61(5):548-52. PubMed ID: 18441153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide YY and appetite control.
    McGowan BM; Bloom SR
    Curr Opin Pharmacol; 2004 Dec; 4(6):583-8. PubMed ID: 15525548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the Enteroendocrine System for Treatment of Obesity.
    Miedzybrodzka EL; Gribble FM; Reimann F
    Handb Exp Pharmacol; 2022; 274():487-513. PubMed ID: 35419620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of solid-phase extraction of plasma in measuring gut metabolic hormones in fasted and fed blood of lean and diet-induced obese rats.
    Reidelberger R; Haver A; Anders K; Apenteng B; Lanio C
    Physiol Rep; 2016 May; 4(10):. PubMed ID: 27207785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How Satiating Are the 'Satiety' Peptides: A Problem of Pharmacology versus Physiology in the Development of Novel Foods for Regulation of Food Intake.
    Lim JJ; Poppitt SD
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31277416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut peptides and the regulation of appetite.
    Huda MS; Wilding JP; Pinkney JH
    Obes Rev; 2006 May; 7(2):163-82. PubMed ID: 16629873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can food intake be reduced with peptide YY3-36?
    Doggrell SA
    Expert Opin Investig Drugs; 2004 Mar; 13(3):285-7. PubMed ID: 15013946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36.
    Pfluger PT; Kampe J; Castaneda TR; Vahl T; D'Alessio DA; Kruthaupt T; Benoit SC; Cuntz U; Rochlitz HJ; Moehlig M; Pfeiffer AF; Koebnick C; Weickert MO; Otto B; Spranger J; Tschöp MH
    J Clin Endocrinol Metab; 2007 Feb; 92(2):583-8. PubMed ID: 17119001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
    Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
    Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-administration of SR141716 with peptide YY3-36 or oxyntomodulin has additive effects on food intake in mice.
    White NE; Dhillo WS; Liu YL; Small CJ; Kennett GA; Gardiner JV; Ghatei MA; Bloom SR
    Diabetes Obes Metab; 2008 Feb; 10(2):167-70. PubMed ID: 17941865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basal and postprandial gut peptides affecting food intake in lean and obese pregnant women.
    Sodowski K; Zwirska-Korczala K; Kuka D; Kukla M; Budziszewska P; Czuba B; Włoch A; Cnota W; Bielański W; Brzozowski T; Rehfeld JF; Zdun R; Konturek PC
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():37-52. PubMed ID: 17443026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut hormones: implications for the treatment of obesity.
    Neary MT; Batterham RL
    Pharmacol Ther; 2009 Oct; 124(1):44-56. PubMed ID: 19560488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat.
    Anini Y; Fu-Cheng X; Cuber JC; Kervran A; Chariot J; Roz C
    Pflugers Arch; 1999 Aug; 438(3):299-306. PubMed ID: 10398859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin.
    Martin NM; Small CJ; Sajedi A; Patterson M; Ghatei MA; Bloom SR
    Int J Obes Relat Metab Disord; 2004 Jul; 28(7):886-93. PubMed ID: 15148507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide hormone isoforms: N-terminally branched PYY3-36 isoforms give improved lipid and fat-cell metabolism in diet-induced obese mice.
    Pedersen SL; Sasikumar PG; Chelur S; Holst B; Artmann A; Jensen KJ; Vrang N
    J Pept Sci; 2010 Nov; 16(11):664-73. PubMed ID: 20853314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut hormones ghrelin, PYY, and GLP-1 in the regulation of energy balance [corrected] and metabolism.
    Perez-Tilve D; Nogueiras R; Mallo F; Benoit SC; Tschoep M
    Endocrine; 2006 Feb; 29(1):61-71. PubMed ID: 16622293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurocircuitry underlying the actions of glucagon-like peptide 1 and peptide YY
    Dumiaty Y; Underwood BM; Phy-Lim J; Chee MJ
    Neuropeptides; 2024 Jun; 105():102427. PubMed ID: 38579490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide YY: food for thought.
    Neary MT; Batterham RL
    Physiol Behav; 2009 Jul; 97(5):616-9. PubMed ID: 19268484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
    Werling M; Fändriks L; Vincent RP; Cross GF; le Roux CW; Olbers T
    Surg Obes Relat Dis; 2014; 10(5):822-8. PubMed ID: 25282191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.